Combination Therapy for Patients With Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Clinical trial NCT02754726 · COMPLETED

Trial details

NCT number: NCT02754726
Sponsor: HonorHealth Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Untreated Metastatic Pancreatic Ductal Adenocarcinoma

Start date: 2016-04-01
Primary completion: 2023-04-11
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.